(Q36001614)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Is ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

7 January 2020

main subject

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Fulvio Zullo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1

S Palomba

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

6

A Colao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

F Orio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

T Russo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

A Falbo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

T Cascella

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

G Lombardi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

796-805

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03347527

7 January 2020

exact match

0 references

cites work

Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Clomiphene citrate-induced perturbations during meiotic maturation and cytogenetic abnormalities in mouse oocytes in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Transplantation of cryopreserved human ovarian tissue results in follicle growth initiation in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Modern use of clomiphene citrate in induction of ovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Cost-effective infertility care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

The use of GnRH antagonists in ovarian stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

The LHRH antagonist cetrorelix: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Concurrent ganirelix and follitropin beta therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Gonadotrophin regimens and oocyte quality in women with polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

The effect of age on the ovarian response to gonadotropin and on pregnancy rate in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Evidence for abnormal granulosa cell responsiveness to follicle-stimulating hormone in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Future use of clomiphene in ovarian stimulation. A role for clomiphene in the 21st century?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Minilaparoscopic ovarian drilling under local anesthesia in patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Laparoscopic treatment of polycystic ovaries with insulated needle cautery: a reappraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Long-term follow-up of patients with polycystic ovary syndrome after laparoscopic ovarian drilling: endocrine and ultrasonographic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to the oral glucose tolerance test in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Effects of laparoscopic ovarian drilling on adrenal steroids in polycystic ovary syndrome patients with and without hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Medical vs. surgical treatment for clomiphene citrate-resistant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

The use of laparoscopic ovarian electrocautery in preventing cancellation of in-vitro fertilization treatment cycles due to risk of ovarian hyperstimulation syndrome in women with polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

In vitro fertilization following laparoscopic ovarian diathermy in patients with polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Impact of metformin therapy on ovarian stimulation and outcome in 'coasted' patients with polycystic ovary syndrome undergoing in-vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Polycystic ovary syndrome: a changing perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

The effects of ovulation induction with gonadotrophins on the ovary and uterus and implications for assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

New concepts in human sperm-zona pellucida interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Mechanism and inhibition of cytochrome P-450 aromatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Mechanistic studies on aromatase and related C-C bond cleaving P-450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Androgens stimulate early stages of follicular growth in the primate ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Aromatase inhibition for ovarian stimulation: future avenues for infertility management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Improved responsiveness of PCOS patients to clomiphene after CYP17a inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

Long-term GnRH analogue treatment is equivalent to laparoscopic laser diathermy in polycystic ovarian syndrome patients with severe ovarian dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347527

A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.

21 January 2018

1 reference

12 December 2020

Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome

1 reference

12 December 2020

Polycystic ovary syndrome

1 reference

12 December 2020

The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study

1 reference

12 December 2020

Endometrial development was improved by transdermal estradiol in patients treated with clomiphene citrate

1 reference

12 December 2020

Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles

1 reference

12 December 2020

Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.

1 reference

12 December 2020

Clomiphene citrate for unexplained subfertility in women.

1 reference

12 December 2020

Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial

1 reference

12 December 2020

The re-incarnation of an old question--clomid effect on oocyte and embryo?

1 reference

12 December 2020

Enhanced follicular recruitment in an in vitro fertilization program: clomiphene alone versus a clomiphene/human menopausal gonadotropin combination

1 reference

12 December 2020

A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test

1 reference

12 December 2020

Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development.

1 reference

12 December 2020

Low-dose FSH stimulation in polycystic ovary syndrome: comparison of 3 FSH-preparations

1 reference

12 December 2020

Exogenous estrogen therapy concurrent with clomiphene citrate--lack of effect on serum sex hormone levels and endometrial thickness

1 reference

12 December 2020

Pure FSH for ovulation induction in patients with polycystic ovary syndrome and resistant to clomiphene citrate therapy

1 reference

12 December 2020

The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease

1 reference

12 December 2020

A prospective study comparing unilateral and bilateral laparoscopic ovarian diathermy in women with the polycystic ovary syndrome.

1 reference

12 December 2020

Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome

1 reference

12 December 2020

Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles

1 reference

12 December 2020

A prospective, randomised, cross-over study comparing the effects of clomiphene citrate and cyclofenil on endometrial morphology in the luteal phase of normal, fertile women

1 reference

12 December 2020

Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women

1 reference

12 December 2020

Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.

1 reference

12 December 2020

Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome

1 reference

12 December 2020

Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease.

1 reference

12 December 2020

Clomiphene citrate: mechanism(s) and site(s) of action--a hypothesis revisited.

1 reference

12 December 2020

Use of ethinyl estradiol to reverse the antiestrogenic effects of clomiphene citrate in patients undergoing intrauterine insemination: a comparative, randomized study

1 reference

12 December 2020

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

1 reference

12 December 2020

Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in

1 reference

12 December 2020

Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome

1 reference

12 December 2020

Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth

1 reference

12 December 2020

Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome

1 reference

12 December 2020

Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy.

1 reference

12 December 2020

Characteristics predictive of response to ovarian diathermy in women with polycystic ovarian syndrome.

1 reference

12 December 2020

Clomiphene citrate augments follicle-stimulating hormone-induced luteinizing hormone receptor content in cultured rat granulosa cells

1 reference

12 December 2020

The effect of ethinyl estradiol on endometrial thickness and uterine volume during ovulation induction by clomiphene citrate

1 reference

12 December 2020

Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome

1 reference

12 December 2020

Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome

1 reference

12 December 2020

Evaluation of adhesion formation after laparoscopic treatment of polycystic ovarian disease.

1 reference

12 December 2020

Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope.

1 reference

12 December 2020

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome

1 reference

12 December 2020

Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial

1 reference

12 December 2020

Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women.

1 reference

12 December 2020

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

1 reference

12 December 2020

Women with polycystic ovary syndrome gain regular menstrual cycles when ageing

1 reference

12 December 2020

Follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in assisted reproduction cycles

1 reference

12 December 2020

Surgical or medical treatment of polycystic ovary syndrome: a cost-benefit analysis

1 reference

12 December 2020

ACOG technical bulletin. Managing the anovulatory state: medical induction of ovulation. Number 197--September 1994 (replaces no. 120, September 1988). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists

1 reference

12 December 2020

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

1 reference

12 December 2020

Effect of estrogen deprivation on the reproductive physiology of male and female primates

1 reference

12 December 2020

Are estrogens of import to primate/human ovarian folliculogenesis?

1 reference

12 December 2020

Exogenous estrogen therapy for treatment of clomiphene citrate-induced cervical mucus abnormalities: is it effective?

1 reference

12 December 2020

Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women

1 reference

12 December 2020

Interference with uterine blood flow by clomiphene citrate in women with unexplained infertility

1 reference

12 December 2020

GnRH antagonist in single-dose applications

1 reference

12 December 2020

Insulin-like growth factors and ovarian follicular development

1 reference

12 December 2020

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

1 reference

12 December 2020

Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipid-lipoprotein levels.

1 reference

12 December 2020

Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

1 reference

12 December 2020

Clomiphene citrate directly impairs endometrial receptivity in the mouse

1 reference

12 December 2020

Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens

1 reference

12 December 2020

Induction of ovulation with purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome.

1 reference

12 December 2020

A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1007/S00404-002-0437-X

Identifiers

DOI

10.1007/BF03347527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference